Title: Crohn's Disease Market Expected To Witness Sublimation With A CAGR Of 3% Between 2024
1Crohn's Disease Market
Report Id PMRREP9665 Category Life Science
Healthcare
2About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage
- Customized Research
- Syndicated Research
- Investment Research
- Social Media Research
- Automotive and Transportation
- Electronics, Semiconductor, and ICT
- Retail and Consumer Products
- Industrial Automation and Equipment
- Chemicals Materials
- Food and Beverages
- Services and Utilities
- Energy, Mining, Oil, and Gas
Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3Crohn's Disease Market Expected To Witness
Sublimation With A CAGR Of 3 Between 2024
- The Crohns Colitis Foundation of America
(CCFA) stated that over 1 Million Americans were
diagnosed with Crohns ulcerative colitis
disorders, with most of them aged above 30.
Growing occurrence of Crohns disease has
triggered a robust demand for its therapeutics. A
survey conducted by the US Center for Disease
Control (CDC) has revealed that the incidence
rate of Crohns disease in the country is 3.1 to
14.6 new cases per 100,000 population annually. - The disease is highly prevalent in developed
countries, especially in individuals who smoke.
According to a study conducted by Persistence
Market Research (PMR), demand for
anti-inflammatory drugs and biologics for
treating Crohns disease will gain traction in
the near future. PMR forecasts that the global
market for Crohns disease is set to reach US
4,474.8 Million by 2024-end, growing at a CAGR of
3 during the assessment period.
Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/9665
4Market Overview
While biologics will continue to remain the most
preferred drug type amongst both healthcare
professionals and patients, the demand for
anti-inflammatory drugs will also witness a
rampant acceleration during the forecast period.
Based on drug type, the anti-inflammatory drug
segment is projected to reach a market valuation
of US 1,095.9 Million by end of the assessment
period. Based on distribution channel, the
hospital pharmacies will continue to be the
leading segment of the market over the forecast
period. Whereas, the retail pharmacies segment is
projected to exhibit the highest growth, reaching
a market valuation of US 1,470.2 Million by
2024. PMRs findings based on regional
assessment suggest that the Crohns disease
market in North America will continue to lead the
pack during the forecast period. The regions
market is expected to value US 3,149.8
Million over 2014. However, Asia-Pacific is
expected to witness the highest CAGR over the
forecast period. The APAC market is projected to
create an absolute opportunity of US 13.2
Million in 2017 over 2016.
Access Full Report _at_ https//www.persistencemarket
research.com/checkout/9665
5(No Transcript)